Michael Steinberg, M.D., is professor and chair of the Department of Radiation Oncology at the David Geffen School of Medicine at UCLA. His professional career spans private, corporate and academic practice and is known for the development of multi-site radiation oncology care networks that are characterized by clinical excellence and community-based clinical research. His work with the UCLA Radiation Oncology network includes the department at Ronald Reagan Medical Center at UCLA, the Children's Hospital Los Angeles and academically-oriented community practices.
Steinberg graduated Occidental College Phi Beta Kappa with a B.A. in chemistry, and was elected to AOA at the University of Southern California School of Medicine. He completed his radiation oncology residency and fellowship at UCLA.
The treatment focus of Steinberg is tumors of the genitourinary system, breast and head and neck. He specializes in the use of technically-advanced treatment modalities such as Stereotactic Body Radiation Therapy (SBRT) and brachytherapy for the treatment of malignancy. Steinberg publishes and is a speaker on issues related to health policy including quality of care, technology assessment, healthcare economics and disparity. He served as the PI for a National Cancer Institute Cancer Disparity Research grant and as a health services research investigator and manuscript author at the RAND Corporation.
Steinberg has been influential in providing input regarding health policy and economic issues on behalf of patients and his specialty through his various leadership roles in radiation oncology. Presently, he is chair of the Executive Oversight Committee for CareConnect, UCLA's innovative electronic health record (EHR) program. He is also the founding chair of the Health Policy Council of American Society for Radiation Oncology (ASTRO) and is currently Chairman of the Board of that organization. He has served two terms on the Medicare Evidence and Coverage Advisory Committee (MedCAC). Dr. Steinberg is the Chair of the Clinical Chair’s for the UCLA Health System.